Geoffrey Shouse

37PUBLICATIONS

176CO-AUTHORS

HaematologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (37)

Sort by Publication Date:

|Jul 04, 2026

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

|Jun 09, 2026

Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

|May 22, 2026

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma.

|May 18, 2026

Cyclin-Dependent Kinase 5 Contributes to Bruton's Tyrosine Kinase Inhibitor Resistance via the IRE1α/XBP1 Axis in Mantle Cell Lymphoma.

|Feb 26, 2026

Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

John Sharp, Paolo Strati, Subodh Bhatta

|Dec 22, 2025

Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL).

Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin

Pageof 7

Frequent Collaborators

12 joint publications

Narendranath Epperla

Reem Karmali

Thomas Ollila

Alex F Herrera

Jason T Romancik

Leo I Gordon

Deborah Stephens

Shuo Ma

Rahul S Bhansali

Jonathon B Cohen

Frequent Collaborators

12 joint publications

Narendranath Epperla

9 joint publications

Reem Karmali

8 joint publications

Thomas Ollila

8 joint publications

Alex F Herrera